Financhill
Back

NovaBay Pharmaceuticals, Inc. Vs. Kinsale Capital Group, Inc. Industry Stock Comparison

Buy
85

NBY
NovaBay Pharmaceuticals, Inc.

Last Price:
$10.57
Seasonality Move:
13.91%
Sell
25

KNSL
Kinsale Capital Group, Inc.

Last Price:
$398.39
Seasonality Move:
8.72%
Buy
85
NovaBay Pharmaceuticals, Inc. (NBY) is a Buy

Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $7.39. The Score for NBY is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
  • NBY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
25
Kinsale Capital Group, Inc. (KNSL) is a Sell

Is Kinsale Capital Group, Inc. a Buy, Sell or Hold?

  • The current Kinsale Capital Group, Inc. [KNSL] share price is $400.81. The Score for KNSL is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KNSL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals, Inc.'s stock price today?

  • The NovaBay Pharmaceuticals, Inc. share price today is $7.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

KNSL Stock Price Chart

What is Kinsale Capital Group, Inc.'s stock price today?

  • The Kinsale Capital Group, Inc. share price today is $400.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KNSL is experiencing slight buying pressure.

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.32 Buy
Relative Strength Index (14 RSI): 79.16 Buy
Chaikin Money Flow: 666192 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.49 - 5.39) Buy
Bollinger Bands (100): (0.53 - 3.39) Buy

KNSL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.33 Buy
Relative Strength Index (14 RSI): 57.46 Buy
Chaikin Money Flow: 17116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (371.89 - 398.61) Buy
Bollinger Bands (100): (386.22 - 451.98) Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.63 Buy
20-day SMA: 4.03 Buy
50-day SMA: 2.26 Buy
200-day SMA: 1.28 Buy
8-day EMA: 5.83 Buy
20-day EMA: 4.41 Buy
50-day EMA: 2.84 Buy
200-day EMA: 1.09 Buy

KNSL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 395.85 Buy
20-day SMA: 387.89 Buy
50-day SMA: 391.06 Buy
200-day SMA: 443.26 Sell
8-day EMA: 395.65 Buy
20-day EMA: 391.72 Buy
50-day EMA: 397.67 Buy
200-day EMA: 429.28 Sell

NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.

Kinsale Capital Group, Inc. Earnings Growth & KNSL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.74 per share, and an increase next year of $2.02 per share.

NovaBay Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kinsale Capital Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):